Estimating the effect of hepatitis C infection on multidrug-resistant tuberculosis treatment outcomes under hypothetical interventions on regimen composition and adherence
American Journal of Epidemiology · 2026
DOI: 10.1093/aje/kwag024 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift American Journal of Epidemiology, 2026. Verfasst von Allison LaHood und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, United States. Hauptthemen laut MEDLINE: Tuberculosis, Multidrug-Resistant, Antitubercular Agents, Hepatitis C. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases of the US National Institutes of Health.
Abstract (Originalsprache)
Hepatitis C virus (HCV) infection is associated with unfavorable multidrug- and rifampicin-resistant (MDR/RR) tuberculosis (TB) outcomes. We examined whether this association would decrease in settings where no participants were lost-to-follow-up or where all adhered to regimens comprised of priority TB drugs. We analyzed data from 1,530 participants with HCV testing in the endTB observational cohort (NCT03259269). We estimated the relative risk of death, treatment failure, and loss-to-follow-up comparing participants with and without HCV, using inverse probability weighting to adjust for confounding. We then estimated relative risks of HCV on death and failure in weighted pseudopopulations representing hypothetical interventions eliminating loss-to-follow-up and ensuring adherence to strong MDR/RR-TB regimens. The unadjusted risk difference comparing participants with and without HCV was 14.1% (95% confidence interval [CI], 8.0%-20.1%), decreasing to 11.0% (95% CI, 3.0%-19.1%) after weighting. In pseudopopulations without loss-to-follow-up or with adequate adherence to strong regimens, the risk differences were 7.7% (95% CI, 0.8%-16.2%) and 7.0% (95% CI,−1.6% to 17.3%), respectively. Adjustment for baseline confounders attenuated the association between HCV and unfavorable outcomes, suggesting these factors partly explain the disparity. Further attenuation after eliminating loss-to-follow-up suggests that improving treatment retention in MDR/RR-TB care may reduce outcome disparities among patients with HCV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, United States.
- Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA 02115, United States.
- CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
- Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London WC1E 7HT, United Kingdom.
- Interactive Research and Development (IRD), Karachi 75190, Pakistan.
- Field Epidemiology Department, Epicentre, Paris 75019, France.
ORCID-Profile: Allison LaHood, James Robins, Helen R Stagg, Sara Sauer, Lorenzo Guglielmetti, Catherine Hewison, Helena Huerga, Palwasha Khan, Uzma Khan, Nino Lomtadze, Carole D Mitnick, Kwonjun Seung, Alena Skrahina, Molly F Franke
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases of the US National Institutes of Health
Zitieren
APA
LaHood, A., Robins, J., Stagg, H. R., Sauer, S., Ahmed, S., Bastard, M., Guglielmetti, L., Hewison, C., Huerga, H., Isani, A. K., Khan, P., Khan, U., Lomtadze, N., Mamsa, S., Melikyan, N., Mitnick, C. D., Rich, M. L., Seung, K., Siddiqui, M. R., …, & Franke, M. F. (2026). Estimating the effect of hepatitis C infection on multidrug-resistant tuberculosis treatment outcomes under hypothetical interventions on regimen composition and adherence. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwag024
Vancouver
LaHood A, Robins J, Stagg HR, Sauer S, Ahmed S, Bastard M, et al. Estimating the effect of hepatitis C infection on multidrug-resistant tuberculosis treatment outcomes under hypothetical interventions on regimen composition and adherence. American Journal of Epidemiology. 2026. doi:10.1093/aje/kwag024
BibTeX
@article{LaHood2026,
author = {LaHood, Allison and Robins, James and Stagg, Helen R and Sauer, Sara and Ahmed, Saman and Bastard, Mathieu and Guglielmetti, Lorenzo and Hewison, Catherine and Huerga, Helena and Isani, Afshan K and Khan, Palwasha and Khan, Uzma and Lomtadze, Nino and Mamsa, Shahid and Melikyan, Nara and Mitnick, Carole D and Rich, Michael L and Seung, Kwonjun and Siddiqui, Muhammad Rafi and Skrahina, Alena and Stambekova, Assel and Tefera, Girum B and Franke, Molly F},
title = {Estimating the effect of hepatitis C infection on multidrug-resistant tuberculosis treatment outcomes under hypothetical interventions on regimen composition and adherence},
journal = {American Journal of Epidemiology},
year = {2026},
doi = {10.1093/aje/kwag024}
}
EUVIMED